204 related articles for article (PubMed ID: 31937922)
1. Tumour-derived extracellular vesicles in blood of metastatic cancer patients associate with overall survival.
Nanou A; Miller MC; Zeune LL; de Wit S; Punt CJA; Groen HJM; Hayes DF; de Bono JS; Terstappen LWMM
Br J Cancer; 2020 Mar; 122(6):801-811. PubMed ID: 31937922
[TBL] [Abstract][Full Text] [Related]
2. HER2 expression on tumor-derived extracellular vesicles and circulating tumor cells in metastatic breast cancer.
Nanou A; Zeune LL; Bidard FC; Pierga JY; Terstappen LWMM
Breast Cancer Res; 2020 Aug; 22(1):86. PubMed ID: 32787900
[TBL] [Abstract][Full Text] [Related]
3. Endothelium-Derived Extracellular Vesicles Associate with Poor Prognosis in Metastatic Colorectal Cancer.
Nanou A; Mol L; Coumans FAW; Koopman M; Punt CJA; Terstappen LWMM
Cells; 2020 Dec; 9(12):. PubMed ID: 33333805
[TBL] [Abstract][Full Text] [Related]
4. Characterizing Circulating Tumor Cells and Tumor-Derived Extracellular Vesicles in Metastatic Castration-Naive and Castration-Resistant Prostate Cancer Patients.
Isebia KT; Dathathri E; Verschoor N; Nanou A; De Jong AC; Coumans FAW; Terstappen LWMM; Kraan J; Martens JWM; Bansal R; Lolkema MP
Cancers (Basel); 2022 Sep; 14(18):. PubMed ID: 36139564
[TBL] [Abstract][Full Text] [Related]
5. Tumor-Derived Extracellular Vesicles as Complementary Prognostic Factors to Circulating Tumor Cells in Metastatic Breast Cancer.
Nanou A; Miao J; Coumans FAW; Dolce EM; Darga E; Barlow W; Smerage JB; Paoletti C; Godwin AK; Pusztai L; Sharma P; Thompson A; Hortobagyi GN; Terstappen LWMM; Hayes DF
JCO Precis Oncol; 2023 Jan; 7():e2200372. PubMed ID: 36634296
[TBL] [Abstract][Full Text] [Related]
6. Large tumour-derived extracellular vesicles as prognostic indicators of metastatic cancer patient survival.
Goberdhan DCI
Br J Cancer; 2023 Feb; 128(3):471-473. PubMed ID: 36385555
[TBL] [Abstract][Full Text] [Related]
7. Circulating tumor cells, tumor-derived extracellular vesicles and plasma cytokeratins in castration-resistant prostate cancer patients.
Nanou A; Coumans FAW; van Dalum G; Zeune LL; Dolling D; Onstenk W; Crespo M; Fontes MS; Rescigno P; Fowler G; Flohr P; Brune C; Sleijfer S; de Bono JS; Terstappen LWMM
Oncotarget; 2018 Apr; 9(27):19283-19293. PubMed ID: 29721202
[TBL] [Abstract][Full Text] [Related]
8. Automated enumeration and phenotypic characterization of CTCs and tdEVs in patients with metastatic castration resistant prostate cancer.
Oeyen S; Liégeois V; De Laere B; Buys A; Strijbos M; Dirix P; Meijnders P; Vermeulen P; Van Laere S; Dirix L
Prostate Cancer Prostatic Dis; 2021 Jun; 24(2):499-506. PubMed ID: 33230201
[TBL] [Abstract][Full Text] [Related]
9. Leukocyte-Derived Extracellular Vesicles in Blood with and without EpCAM Enrichment.
Nanou A; Zeune LL; Terstappen LWMM
Cells; 2019 Aug; 8(8):. PubMed ID: 31434250
[TBL] [Abstract][Full Text] [Related]
10. Associations between AR-V7 status in circulating tumour cells, circulating tumour cell count and survival in men with metastatic castration-resistant prostate cancer.
Belderbos BPS; Sieuwerts AM; Hoop EO; Mostert B; Kraan J; Hamberg P; Van MN; Beaufort CM; Onstenk W; van Soest RJ; Martens J; Sleijfer S; de Wit R; Mathijssen RHJ; Lolkema MP
Eur J Cancer; 2019 Nov; 121():48-54. PubMed ID: 31542641
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal enumeration and cluster evaluation of circulating tumor cells improve prognostication for patients with newly diagnosed metastatic breast cancer in a prospective observational trial.
Larsson AM; Jansson S; Bendahl PO; Levin Tykjaer Jörgensen C; Loman N; Graffman C; Lundgren L; Aaltonen K; Rydén L
Breast Cancer Res; 2018 Jun; 20(1):48. PubMed ID: 29884204
[TBL] [Abstract][Full Text] [Related]
12. Scanning Electron Microscopy of Circulating Tumor Cells and Tumor-Derived Extracellular Vesicles.
Nanou A; Crespo M; Flohr P; De Bono JS; Terstappen LWMM
Cancers (Basel); 2018 Oct; 10(11):. PubMed ID: 30384500
[TBL] [Abstract][Full Text] [Related]
13. Detection and prognostic significance of circulating tumour cells in patients with metastatic breast cancer according to immunohistochemical subtypes.
Peeters DJ; van Dam PJ; Van den Eynden GG; Rutten A; Wuyts H; Pouillon L; Peeters M; Pauwels P; Van Laere SJ; van Dam PA; Vermeulen PB; Dirix LY
Br J Cancer; 2014 Jan; 110(2):375-83. PubMed ID: 24366294
[TBL] [Abstract][Full Text] [Related]
14. Assessment of the Efficacy and Clinical Utility of Different Circulating Tumor Cell (CTC) Detection Assays in Patients with Chemotherapy-Naïve Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC).
Papadaki MA; Messaritakis I; Fiste O; Souglakos J; Politaki E; Kotsakis A; Georgoulias V; Mavroudis D; Agelaki S
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33477700
[TBL] [Abstract][Full Text] [Related]
15. Clinical Utility of Circulating Tumour Cell Androgen Receptor Splice Variant-7 Status in Metastatic Castration-resistant Prostate Cancer.
Sharp A; Welti JC; Lambros MBK; Dolling D; Rodrigues DN; Pope L; Aversa C; Figueiredo I; Fraser J; Ahmad Z; Lu C; Rescigno P; Kolinsky M; Bertan C; Seed G; Riisnaes R; Miranda S; Crespo M; Pereira R; Ferreira A; Fowler G; Ebbs B; Flohr P; Neeb A; Bianchini D; Petremolo A; Sumanasuriya S; Paschalis A; Mateo J; Tunariu N; Yuan W; Carreira S; Plymate SR; Luo J; de Bono JS
Eur Urol; 2019 Nov; 76(5):676-685. PubMed ID: 31036442
[TBL] [Abstract][Full Text] [Related]
16. Filtration based assessment of CTCs and CellSearch® based assessment are both powerful predictors of prognosis for metastatic breast cancer patients.
Huebner H; Fasching PA; Gumbrecht W; Jud S; Rauh C; Matzas M; Paulicka P; Friedrich K; Lux MP; Volz B; Gass P; Häberle L; Meier-Stiegen F; Hartkopf A; Neubauer H; Almstedt K; Beckmann MW; Fehm TN; Ruebner M
BMC Cancer; 2018 Feb; 18(1):204. PubMed ID: 29463222
[TBL] [Abstract][Full Text] [Related]
17. mRNA expression profiles in circulating tumor cells of metastatic colorectal cancer patients.
Mostert B; Sieuwerts AM; Bolt-de Vries J; Kraan J; Lalmahomed Z; van Galen A; van der Spoel P; de Weerd V; Ramírez-Moreno R; Smid M; Verhoef C; IJzermans JN; Gratama JW; Sleijfer S; Foekens JA; Martens JW
Mol Oncol; 2015 Apr; 9(4):920-32. PubMed ID: 25655581
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of circulating tumour cell enumeration (Epic Sciences) as a prognostic biomarker in men with metastatic castration-resistant prostate cancer.
Scher HI; Armstrong AJ; Schonhoft JD; Gill A; Zhao JL; Barnett E; Carbone E; Lu J; Antonarakis ES; Luo J; Tagawa S; Dos Anjos CH; Yang Q; George D; Szmulewitz R; Danila DC; Wenstrup R; Gonen M; Halabi S
Eur J Cancer; 2021 Jun; 150():83-94. PubMed ID: 33894633
[TBL] [Abstract][Full Text] [Related]
19. Size-based isolation of circulating tumor cells in lung cancer patients using a microcavity array system.
Hosokawa M; Kenmotsu H; Koh Y; Yoshino T; Yoshikawa T; Naito T; Takahashi T; Murakami H; Nakamura Y; Tsuya A; Shukuya T; Ono A; Akamatsu H; Watanabe R; Ono S; Mori K; Kanbara H; Yamaguchi K; Tanaka T; Matsunaga T; Yamamoto N
PLoS One; 2013; 8(6):e67466. PubMed ID: 23840710
[TBL] [Abstract][Full Text] [Related]
20. Incorporating MicroRNA into Molecular Phenotypes of Circulating Tumor Cells Enhances the Prognostic Accuracy for Patients with Metastatic Breast Cancer.
Tan W; Liang G; Xie X; Jiang W; Tan L; Sanders AJ; Liu Z; Ling Y; Zhong W; Tian Z; Lin W; Gong C
Oncologist; 2019 Nov; 24(11):e1044-e1054. PubMed ID: 31300482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
